Aferna Overview
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Aferna General Information
Description
Developer of molecular tools designed to expand the potential of biology to help plants grow healthier. The company develops ribonucleic acid-based molecular tools to create beneficial crop traits by working in partnership with nature, enabling agriculture to produce more robust crops and contribute to environmental well-being.
Contact Information
Website
www.afernabio.comCorporate Office
- 1100 Corporate Square
- Suite 175
- Saint Louis, MO 63132
- United States
Corporate Office
- 1100 Corporate Square
- Suite 175
- Saint Louis, MO 63132
- United States
Aferna Timeline
Aferna Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Jan-2026 | Completed | Startup | |||
| 2. Early Stage VC | 04-Jun-2025 | Completed | Startup | |||
| 1. Early Stage VC | 01-Nov-2022 | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aferna Patents
Aferna Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024244118-A1 | Plants having increased yield, biomass, and stress tolerance | Pending | 05-Apr-2023 | ||
| EP-4687434-A2 | Plants having increased yield, biomass, and stress tolerance | Pending | 05-Apr-2023 | ||
| US-20260275370-A1 | Plants having increased yield, biomass, and stress tolerance | Pending | 05-Apr-2023 | ||
| WO-2024211438-A2 | Plants having increased yield, biomass, and stress tolerance | Inactive | 05-Apr-2023 | ||
| WO-2024211438-A3 | Plants having increased yield, biomass, and stress tolerance | Inactive | 05-Apr-2023 | C12N15/8261 |
Aferna Signals
Aferna Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bayer | Corporation | Minority | ||
| Missouri Technology Corporation | Venture Capital | Minority | ||
| BioGenerator Ventures | Venture Capital | Minority | ||
| Plaisance Capital Management | Venture Capital | Minority |
Aferna FAQs
-
Where is Aferna headquartered?
Aferna is headquartered in Saint Louis, MO.
-
What is the size of Aferna?
Aferna has 4 total employees.
-
What industry is Aferna in?
Aferna’s primary industry is Other Commercial Products.
-
Is Aferna a private or public company?
Aferna is a Private company.
-
What is Aferna’s current revenue?
The current revenue for Aferna is .
-
How much funding has Aferna raised over time?
Aferna has raised $4M.
-
Who are Aferna’s investors?
Bayer, Missouri Technology Corporation, BioGenerator Ventures, and Plaisance Capital Management have invested in Aferna.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process